Lack of Bridge to Recovery in Pediatric Dilated Cardiomyopathy With Left Ventricular Noncompaction

Moyu Hasegawa1, Masaki Taira1, Yuji Tominaga1

  • 1Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Yamadaoka, Osaka, Japan.

Insights

Pediatric patients with dilated cardiomyopathy and left ventricular noncompaction had lower recovery rates using the Berlin Heart EXCOR device. Myocardial fibrosis was higher, and cardiac function did not improve in this group.

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Surgery
  • Histopathology

Background:

  • Assessing the Berlin Heart EXCOR as a bridge to recovery in pediatric dilated cardiomyopathy.
  • Investigating the impact of left ventricular noncompaction phenotype on recovery.
  • Examining histologic characteristics in affected children.

Purpose of the Study:

  • To evaluate the efficacy of the Berlin Heart EXCOR in pediatric patients with dilated cardiomyopathy.
  • To determine if the presence of left ventricular noncompaction affects cardiac recovery.
  • To compare histologic features and left ventricular function between patient groups.

Main Methods:

  • Retrospective analysis of 17 pediatric patients with dilated cardiomyopathy treated with Berlin Heart EXCOR (2013-2020).
  • Classification into dilated cardiomyopathy (DCM) group and DCM with left ventricular noncompaction (DCM-LVNC) phenotype group.
  • Histologic examination of myocardium and comparison of left ventricular function pre- and post-implantation.

Main Results:

  • No cardiac recovery observed in the DCM-LVNC group.
  • 55% of patients in the DCM group achieved recovery and device explantation.
  • Significantly higher myocardial fibrosis in the DCM-LVNC group (P < .05).
  • Significant improvement in ejection fraction and end-diastolic diameter in the DCM group (P < .001), but not in the DCM-LVNC group.

Conclusions:

  • The left ventricular noncompaction phenotype may hinder cardiac recovery in pediatric patients with dilated cardiomyopathy supported by the Berlin Heart EXCOR.
  • Histologic differences, specifically increased fibrosis, may contribute to poorer outcomes in the DCM-LVNC group.
Abstract

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
826
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
952
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753